Blow for Genzyme as FDA finds fault with Allston facility
March 13, 2009Research and Development, Sales and Marketing FDA, Genzyme
The chances of approval for Genzyme's new Pompe disease drug Lumizyme have diminished dramatically after the US Food and Drug …
Working Life: Andrew Clark
March 13, 2009Research and Development, Sales and Marketing UCB, library
How did you find your way into your current role? On return from a working holiday to New Zealand I …
Government picks top-level NHS-academic research centres
March 12, 2009Research and Development Academic
Five establishments have been named by the government as Academic Health Science Centres (AHSCs). The centres – UCL Partners, Cambridge …
Roche buys out Genentech with increased bid
March 12, 2009Sales and Marketing MA, Roche
Roche has finally struck a deal to acquire Genentech after raising its cash offer, putting an end to a prolonged …
Cervarix adverse reactions as expected, says MHRA
March 11, 2009Sales and Marketing GSK, vaccines
The government has played down reports about adverse reactions to GlaxoSmithKline's Cervarix, saying they are in line with expectations. The …
Recession helping smokers kick the habit
March 11, 2009Sales and Marketing healthcare
New research compiled to mark the UK's No Smoking Day suggests a third of the country's smokers are thinking about …
Foundation trusts’ private income limit could be dropped
March 11, 2009NHS
The House of Lords is set to debate an amendment to the Health Bill which could remove the private patient …
Obama ends stem cell funding ban
March 10, 2009Research and Development US, stem cell
President Obama has lifted the US ban on federal funding for new stem cell research, signalling another marked departure in …
Making a sales pitch in the ‘war for talent’
March 10, 2009Business Services UCB, recruitment
When I joined Celltech (now part of UCB) over 20 years ago it was difficult to attract candidates who valued …
Are biosimilars delivering the goods in the EU?
March 10, 2009Manufacturing and Production, Research and Development biosimilars
In January, leading pharmaceutical experts attended the 2009 Forum Institute seminar on biosimilars, and the challenges involved in their successful …
Merck unveils $41 billion takeover of Schering-Plough
March 9, 2009Sales and Marketing MA, Merck
Merck is to acquire Schering-Plough for $41.1 billion, creating a new industry giant to challenge Pfizer in terms of its …
GSW unveils new European offering
March 6, 2009Medical Communications GSW
GSW Worldwide, one of the biggest global healthcare advertising agencies has announced the launch of a new pan-European offering.GSW is …
P&G sponsors ulcerative colitis DVD
March 6, 2009Sales and Marketing GI, digi
Procter & Gamble Pharmaceuticals is sponsoring and distributing a new educational DVD that aims to explain ulcerative colitis (UC) to …
UCB plans new Belgian biomanufacturing plant
March 6, 2009Manufacturing and Production UCB
Belgian biopharmaceutical company UCB has earmarked euros 65 million for the construction of its first biologics manufacturing plant in Braine-l'Alleud. …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
